CLOTRIMAZOLE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
CLOTRIMAZOLE
Generic name
CLOTRIMAZOLE
Manufacturer
ALLIED TRADE LINK LLC
Product type
HUMAN OTC DRUG
SPL set ID
266d7b94-2954-4831-e063-6394a90a3f33
SPL ID
266d7b94-2955-4831-e063-6394a90a3f33
Version
1
Effective date
2024-11-08
Source export date
2026-09-28
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:15:40
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

For External Use Only Do not use On children under 2 years of age unless directed by a doctor For diaper rash. When using this product Avoid contact with the eyes Stop use and ask a doctor if Irritation occurs There is no improvement within 2 weeks when used for the treatment of jock itch There is no improvement within 4 weeks when used for athlete’s foot or ringworm

warnings and cautions

Warnings For External Use Only Do not use On children under 2 years of age unless directed by a doctor For diaper rash. When using this product Avoid contact with the eyes Stop use and ask a doctor if Irritation occurs There is no improvement within 2 weeks when used for the treatment of jock itch There is no improvement within 4 weeks when used for athlete’s foot or ringworm

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.